5:13 PM
 | 
May 19, 2010
 |  BC Extra  |  Top Story

FDA appoints biosimilars director

FDA has started to create a structure for reviewing biosimilars applications, including the establishment of a new position, Associate Director for Biosimilars, John Jenkins, director of the Office of New Drugs (OND), revealed in an internal memo sent to FDA...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >